Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

por Broughton, Edward I., Gooden, Kyna M., Mycock, Katie L., Rajkovic, Ivana, Taylor-Stokes, Gavin
Publicado 2022

1564. Virological Suppression in People with HIV-1 (PWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups despite Older PWH Having Increased Rates of Comorb...

por Brogan, Andrew P, Slim, Jihad, Verdier, Gustavo, Harper, Gavin, Mycock, Katie L, Wallis, Hannah, Donovan, Cynthia
Publicado 2023

Treatment and disease management patterns for bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer in North America, Europe and Asia: A real-world data analysis

por Broughton, Edward I., Chun, Danielle S., Gooden, Kyna M., Mycock, Katie L., Rajkovic, Ivana, Taylor-Stokes, Gavin
Publicado 2022

1279. Real World Treatment Experience of Treatment-Naïve People with HIV who Initiated Treatment with Single Tablet Dolutegravir/Lamivudine in a Test and Treat setting in the US.

por Kuretski, Jennifer, Donovan, Cindy, Harper, Gavin, Merrill, Deanna, Mycock, Katie L, Oglesby, Alan, Metzner, Aimee, Patarroyo, Jimena
Publicado 2022

1278. Real World Treatment Experience of Single Tablet Dolutegravir/Lamivudine in Those Naïve to Treatment with Baseline Viral Loads ≥ 100,000 copies/mL in the US

por Benson, Paul, Donovan, Cindy, Harper, Gavin, Merrill, Deanna, Mycock, Katie L, Oglesby, Alan, Patarroyo, Jimena, Metzner, Aimee
Publicado 2022

2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen

por Ward, Douglas, Scheibel, Steven F, Ramgopal, Moti, Riedel, David J, Garris, Cindy, Oglesby, Alan, Waller, John E, Roberts, Jenna, Mycock, Katie L, Dhir, Shelly, Bonnie, Collins, Megan, Dominguez, Mrus, Joseph, Pike, James
Publicado 2019